Nexstim Plc (FRA:5NX)

Revenue by Product

Financials in millions EUR. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Diagnostics Systems	3.15M
Diagnostics Systems Growth	1.23%
Therapy Continuous	2.55M
Therapy Continuous Growth	28.61%
Therapy Systems	1.64M
Therapy Systems Growth	68.73%
Diagnostics Continuous	1.40M
Diagnostics Continuous Growth	18.23%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Other	71.01K
Other Growth	-72.87%
North America	3.31M
North America Growth	1.98%
Rest of Europe	3.03M
Rest of Europe Growth	35.19%
Finland	2.32M
Finland Growth	55.28%
Other	71.01K
Other Growth	-72.87%